NASDAQ:ALIM
Alimera Sciences Stock News
$3.34
-0.100 (-2.91%)
At Close: Apr 19, 2024
Alimera Announces Data to Be Highlighted In Scientific Programming At Annual Congress
12:00pm, Wednesday, 13'th Jul 2022 GlobeNewswire Inc.
ILUVIEN® data to be presented onsite at the annual American Society of Retina Specialists (ASRS) conference. ILUVIEN® data to be presented onsite at the annual American Society of Retina Specialists
Alimera Announces Approval and Pricing Granted for ILUVIEN® for Uveitis in Italy
12:00pm, Friday, 08'th Jul 2022 GlobeNewswire Inc.
ILUVIEN receives approval and pricing for non-infectious uveitis affecting the posterior segment indication in July; launch to follow ILUVIEN receives approval and pricing for non-infectious uveitis a
Phase III Clinical Study IND Accepted in China for Alimera’s Fluocinolone Acetonide Intravitreal Implant
12:03pm, Wednesday, 08'th Jun 2022 GlobeNewswire Inc.
ATLANTA, June 08, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partn
Phase 4 PALADIN Study Confirms Positive Predictive Value of Corticosteroid Course Prior to ILUVIEN® Use for IOP Outcomes
12:03pm, Thursday, 12'th May 2022 GlobeNewswire Inc.
Recently presented data further demonstrate steroid challenge is highly predictive of IOP response post-FAc regardless of steroid choice Recently presented data further demonstrate steroid challenge i
Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates
01:15pm, Monday, 09'th May 2022 Zacks Investment Research
Alimera Sciences (ALIM) delivered earnings and revenue surprises of -26.87% and 8.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Alimera Sciences, Inc (ALIM) CEO Richard Eiswirth on Q1 2022 Results - Earnings Call Transcript
11:42am, Monday, 09'th May 2022
Alimera Sciences, Inc (NASDAQ:ALIM ) Q1 2022 Earnings Conference Call May 9, 2022 9:00 AM ET Company Participants Scott Gordon - CORE IR Richard Eiswirth - President and Chief Executive Officer Phil J
Alimera Sciences to Report First Quarter 2022 Financial Results on Monday, May 9, 2022, and Provide Corporate Update
12:00pm, Friday, 06'th May 2022 GlobeNewswire Inc.
Conference Call to be held the same day at 9:00am Eastern Time Conference Call to be held the same day at 9:00am Eastern Time
Ocugen (OCGN) Reports Q1 Loss, Misses Revenue Estimates
11:45am, Friday, 06'th May 2022 Zacks Investment Research
Ocugen (OCGN) delivered earnings and revenue surprises of -280% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Alimera Sciences to Report First Quarter 2022 Financial Results on Monday, May 9, 2022, and Provide Corporate Update
08:00am, Friday, 06'th May 2022
Conference Call to be held the same day at 9:00am Eastern Time Conference Call to be held the same day at 9:00am Eastern Time
Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates
09:55pm, Thursday, 05'th May 2022 Zacks Investment Research
Celldex (CLDX) delivered earnings and revenue surprises of -6.52% and 76.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 26th
11:24am, Tuesday, 26'th Apr 2022 Zacks Investment Research
ANIK, ALIM, and ADAP have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2022
New Strong Sell Stocks for April 26th
09:02am, Tuesday, 26'th Apr 2022
ANIK, ALIM, and ADAP have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2022
Trevena (TRVN) Reports Q4 Loss, Lags Revenue Estimates
12:15pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Trevena (TRVN) delivered earnings and revenue surprises of 11.11% and 100.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for March 30th
09:44am, Wednesday, 30'th Mar 2022 Zacks Investment Research
ALIM, APPF, and CNNE have been added to the Zacks Rank #5 (Strong Sell) List on March 30, 2022.
New Strong Sell Stocks for March 30th
06:47am, Wednesday, 30'th Mar 2022
ALIM, APPF, and CNNE have been added to the Zacks Rank #5 (Strong Sell) List on March 30, 2022.
